Literature DB >> 2236291

Molluscicidal and antischistosomal activities of Zingiber officinale.

C O Adewunmi1, B O Oguntimein, P Furu.   

Abstract

Experiments were conducted to study the major constituents of Zingiber officinale responsible for its molluscicidal activity and the effect of the active component on different stages of Schistosoma mansoni. Gingerol and shogaol exhibited potent molluscicidal activity on Biomphalaria glabrata. Gingerol (5.0 ppm) completely abolished the infectivity of Schistosoma mansoni miracidia and cercariae in B. glabrata and mice, respectively, indicating that the molluscicide is capable of interrupting schistosome transmission at a concentration lower than its molluscicidal concentrations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2236291     DOI: 10.1055/s-2006-960986

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  4 in total

1.  Fascioliasis control: in vivo and in vitro phytotherapy of vector snail to kill fasciola larva.

Authors:  Kumari Sunita; D K Singh
Journal:  J Parasitol Res       Date:  2011-10-23

Review 2.  The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases.

Authors:  Peter Mubanga Cheuka; Godfrey Mayoka; Peggoty Mutai; Kelly Chibale
Journal:  Molecules       Date:  2016-12-31       Impact factor: 4.411

3.  Synthesis of analogues of gingerol and shogaol, the active pungent principles from the rhizomes of Zingiber officinale and evaluation of their anti-platelet aggregation effects.

Authors:  Hung-Cheng Shih; Ching-Yuh Chern; Ping-Chung Kuo; You-Cheng Wu; Yu-Yi Chan; Yu-Ren Liao; Che-Ming Teng; Tian-Shung Wu
Journal:  Int J Mol Sci       Date:  2014-03-04       Impact factor: 5.923

4.  In vitro phytotherapy of vector snails by binary combinations of larvicidal active components in effective control of fascioliasis.

Authors:  Kumari Sunita; Pradeep Kumar; Vinay Kumar Singh; Dinesh Kumar Singh
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013 Sep-Oct       Impact factor: 1.846

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.